Concepts (186)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Extracellular Vesicles | 5 | 2023 | 59 | 0.650 |
Why?
|
| RNA | 5 | 2023 | 606 | 0.300 |
Why?
|
| Workflow | 1 | 2025 | 135 | 0.220 |
Why?
|
| Exosomes | 1 | 2023 | 57 | 0.200 |
Why?
|
| Receptors, Antigen, T-Cell | 4 | 1989 | 504 | 0.190 |
Why?
|
| Software | 2 | 2025 | 732 | 0.190 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 5 | 1993 | 60 | 0.190 |
Why?
|
| Cell-Free Nucleic Acids | 2 | 2019 | 61 | 0.180 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2004 | 1068 | 0.170 |
Why?
|
| Immunoglobulin Variable Region | 2 | 1991 | 52 | 0.170 |
Why?
|
| Thymus Gland | 5 | 1993 | 106 | 0.170 |
Why?
|
| Computational Biology | 1 | 2025 | 884 | 0.160 |
Why?
|
| Cell Communication | 1 | 2019 | 190 | 0.140 |
Why?
|
| Gene Expression Profiling | 1 | 2004 | 1912 | 0.130 |
Why?
|
| Endothelial Cells | 1 | 2020 | 539 | 0.130 |
Why?
|
| Gene Ontology | 1 | 2016 | 55 | 0.120 |
Why?
|
| Glioblastoma | 1 | 2020 | 373 | 0.120 |
Why?
|
| MicroRNAs | 2 | 2020 | 945 | 0.120 |
Why?
|
| Spine | 1 | 2016 | 147 | 0.120 |
Why?
|
| Epigenomics | 1 | 2016 | 196 | 0.120 |
Why?
|
| Glioma | 1 | 2020 | 536 | 0.110 |
Why?
|
| Transcription, Genetic | 8 | 2004 | 1758 | 0.110 |
Why?
|
| Health Status | 1 | 2016 | 414 | 0.110 |
Why?
|
| DNA-Binding Proteins | 5 | 2004 | 2145 | 0.100 |
Why?
|
| Hypoxia | 2 | 2005 | 266 | 0.100 |
Why?
|
| Polymerase Chain Reaction | 4 | 1992 | 1586 | 0.100 |
Why?
|
| Immunoglobulin alpha-Chains | 1 | 1991 | 1 | 0.090 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1991 | 3 | 0.090 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 1 | 1991 | 10 | 0.090 |
Why?
|
| T-Lymphocytes | 4 | 2004 | 1770 | 0.090 |
Why?
|
| RNA, Messenger | 7 | 2004 | 2880 | 0.090 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1989 | 4 | 0.080 |
Why?
|
| Recombination, Genetic | 3 | 2005 | 451 | 0.080 |
Why?
|
| Base Sequence | 8 | 1994 | 3153 | 0.080 |
Why?
|
| Nucleic Acid Amplification Techniques | 1 | 1989 | 72 | 0.080 |
Why?
|
| Molecular Sequence Data | 8 | 1994 | 3958 | 0.080 |
Why?
|
| Major Histocompatibility Complex | 1 | 1988 | 53 | 0.070 |
Why?
|
| Brain | 1 | 2020 | 3220 | 0.070 |
Why?
|
| Trans-Activators | 3 | 1997 | 832 | 0.070 |
Why?
|
| Quality of Life | 1 | 2016 | 2160 | 0.060 |
Why?
|
| Transcription Factors | 5 | 2004 | 2720 | 0.060 |
Why?
|
| Cloning, Molecular | 3 | 1992 | 911 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 6 | 1994 | 1085 | 0.060 |
Why?
|
| Mice | 12 | 2004 | 18910 | 0.060 |
Why?
|
| DNA Repair | 2 | 2005 | 573 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 2 | 2016 | 1827 | 0.060 |
Why?
|
| DNA Restriction Enzymes | 1 | 2004 | 122 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 3 | 2004 | 1422 | 0.050 |
Why?
|
| DNA Fragmentation | 1 | 2004 | 60 | 0.050 |
Why?
|
| Galactose | 1 | 2004 | 57 | 0.050 |
Why?
|
| User-Computer Interface | 1 | 2025 | 167 | 0.050 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2753 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2016 | 2124 | 0.050 |
Why?
|
| Muscles | 1 | 2004 | 252 | 0.050 |
Why?
|
| 3' Untranslated Regions | 1 | 2004 | 180 | 0.050 |
Why?
|
| DNA, Complementary | 1 | 2004 | 470 | 0.050 |
Why?
|
| Transgenes | 1 | 2004 | 344 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 3042 | 0.050 |
Why?
|
| Animals | 14 | 2004 | 36120 | 0.050 |
Why?
|
| Internet | 1 | 2025 | 403 | 0.050 |
Why?
|
| Biomarkers | 2 | 2023 | 3417 | 0.050 |
Why?
|
| Humans | 13 | 2025 | 133492 | 0.050 |
Why?
|
| Environmental Exposure | 1 | 2023 | 237 | 0.040 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 1321 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 2004 | 440 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2004 | 616 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2004 | 786 | 0.040 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2000 | 79 | 0.040 |
Why?
|
| Circulating MicroRNA | 1 | 2019 | 10 | 0.040 |
Why?
|
| Knowledge Bases | 1 | 2019 | 40 | 0.040 |
Why?
|
| Body Fluids | 1 | 2019 | 48 | 0.040 |
Why?
|
| Gene Expression | 3 | 1999 | 1608 | 0.040 |
Why?
|
| Neovascularization, Pathologic | 1 | 2020 | 260 | 0.040 |
Why?
|
| Bile Acids and Salts | 1 | 2000 | 258 | 0.040 |
Why?
|
| Zinc Fingers | 2 | 1997 | 125 | 0.030 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2000 | 396 | 0.030 |
Why?
|
| Muscle, Skeletal | 1 | 2004 | 1037 | 0.030 |
Why?
|
| Placental Lactogen | 1 | 1997 | 3 | 0.030 |
Why?
|
| Nervous System | 2 | 1995 | 130 | 0.030 |
Why?
|
| Gene Expression Regulation | 2 | 2004 | 2649 | 0.030 |
Why?
|
| Algorithms | 1 | 2004 | 1730 | 0.030 |
Why?
|
| Web Browser | 1 | 2016 | 8 | 0.030 |
Why?
|
| Africa | 1 | 2016 | 138 | 0.030 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 422 | 0.030 |
Why?
|
| Trophoblasts | 1 | 1997 | 122 | 0.030 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 2 | 1993 | 6 | 0.030 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 1995 | 9 | 0.030 |
Why?
|
| Disease Progression | 2 | 2016 | 2249 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2016 | 463 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2016 | 162 | 0.030 |
Why?
|
| Oligonucleotide Probes | 2 | 1992 | 98 | 0.030 |
Why?
|
| Transfection | 3 | 2005 | 1095 | 0.030 |
Why?
|
| Propensity Score | 1 | 2016 | 263 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 2 | 1997 | 1049 | 0.030 |
Why?
|
| Stromal Cells | 1 | 2016 | 314 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1995 | 185 | 0.030 |
Why?
|
| Aging | 2 | 1992 | 1270 | 0.030 |
Why?
|
| Cell Line, Tumor | 2 | 2016 | 3796 | 0.030 |
Why?
|
| Databases, Factual | 1 | 1999 | 1255 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 1995 | 132 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2016 | 362 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 707 | 0.030 |
Why?
|
| Adipose Tissue | 1 | 2016 | 510 | 0.030 |
Why?
|
| Databases, Genetic | 1 | 2016 | 503 | 0.030 |
Why?
|
| Cell Cycle | 2 | 2005 | 620 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 294 | 0.020 |
Why?
|
| Gene Rearrangement, delta-Chain T-Cell Antigen Receptor | 1 | 1992 | 1 | 0.020 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 1 | 1992 | 32 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 699 | 0.020 |
Why?
|
| GATA3 Transcription Factor | 3 | 1997 | 44 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1989 | 314 | 0.020 |
Why?
|
| Point Mutation | 1 | 1992 | 357 | 0.020 |
Why?
|
| Oligonucleotides | 1 | 1991 | 94 | 0.020 |
Why?
|
| Genes | 2 | 1989 | 448 | 0.020 |
Why?
|
| Spleen | 2 | 1989 | 286 | 0.020 |
Why?
|
| Cells, Cultured | 4 | 2000 | 3141 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2016 | 1141 | 0.020 |
Why?
|
| Abnormalities, Multiple | 1 | 1995 | 982 | 0.020 |
Why?
|
| Biotechnology | 1 | 1989 | 61 | 0.020 |
Why?
|
| Female | 5 | 2019 | 71527 | 0.020 |
Why?
|
| Chromosome Mapping | 1 | 1991 | 1118 | 0.020 |
Why?
|
| Male | 6 | 2019 | 65634 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1988 | 400 | 0.020 |
Why?
|
| Liver | 1 | 1995 | 1845 | 0.020 |
Why?
|
| Kidney | 1 | 1994 | 1382 | 0.020 |
Why?
|
| Cell Line | 2 | 1989 | 2858 | 0.020 |
Why?
|
| Adult | 2 | 2019 | 31765 | 0.020 |
Why?
|
| Phenotype | 1 | 2016 | 4581 | 0.020 |
Why?
|
| GATA2 Transcription Factor | 2 | 1997 | 47 | 0.020 |
Why?
|
| Rad51 Recombinase | 1 | 2005 | 31 | 0.020 |
Why?
|
| Luciferases | 1 | 2005 | 136 | 0.010 |
Why?
|
| Cell Separation | 1 | 2005 | 231 | 0.010 |
Why?
|
| In Situ Hybridization | 2 | 1997 | 479 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2004 | 19 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2004 | 103 | 0.010 |
Why?
|
| DNA | 1 | 1989 | 1675 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2005 | 814 | 0.010 |
Why?
|
| Rats | 2 | 2000 | 3848 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2004 | 712 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 9968 | 0.010 |
Why?
|
| Iron | 1 | 2004 | 303 | 0.010 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2004 | 260 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 6 | 1 | 2000 | 7 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2000 | 22 | 0.010 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 1 | 2000 | 35 | 0.010 |
Why?
|
| Rats, Inbred F344 | 1 | 2000 | 107 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2000 | 269 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2016 | 13088 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2000 | 256 | 0.010 |
Why?
|
| Hepatocytes | 1 | 2000 | 246 | 0.010 |
Why?
|
| Cardiomegaly | 1 | 1999 | 121 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2016 | 17562 | 0.010 |
Why?
|
| Nuclear Proteins | 1 | 2004 | 1340 | 0.010 |
Why?
|
| Adolescent | 1 | 2016 | 20587 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1999 | 839 | 0.010 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2000 | 591 | 0.010 |
Why?
|
| RNA, Antisense | 1 | 1997 | 36 | 0.010 |
Why?
|
| Prolactin | 1 | 1997 | 116 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1999 | 1302 | 0.010 |
Why?
|
| Litter Size | 1 | 1995 | 25 | 0.010 |
Why?
|
| Craniofacial Dysostosis | 1 | 1995 | 19 | 0.010 |
Why?
|
| Genes, Lethal | 1 | 1995 | 77 | 0.010 |
Why?
|
| Repressor Proteins | 1 | 2000 | 872 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 1599 | 0.010 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 1997 | 299 | 0.010 |
Why?
|
| Fetal Death | 1 | 1995 | 120 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1997 | 381 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 1999 | 2153 | 0.010 |
Why?
|
| Consensus Sequence | 1 | 1993 | 59 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1993 | 140 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 1995 | 467 | 0.010 |
Why?
|
| Cell Movement | 1 | 1997 | 907 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 1749 | 0.010 |
Why?
|
| Placenta | 1 | 1997 | 548 | 0.010 |
Why?
|
| Sequence Alignment | 1 | 1993 | 631 | 0.010 |
Why?
|
| Neural Tube Defects | 1 | 1995 | 359 | 0.010 |
Why?
|
| Gestational Age | 1 | 1995 | 1230 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 1995 | 554 | 0.010 |
Why?
|
| Genotype | 1 | 1995 | 2715 | 0.000 |
Why?
|
| Macromolecular Substances | 1 | 1989 | 186 | 0.000 |
Why?
|
| Mice, Transgenic | 1 | 1994 | 2520 | 0.000 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 2784 | 0.000 |
Why?
|
| Mice, Knockout | 1 | 1995 | 3978 | 0.000 |
Why?
|
| Mice, Inbred C57BL | 1 | 1993 | 4826 | 0.000 |
Why?
|
| Mutation | 1 | 1997 | 6336 | 0.000 |
Why?
|
| Genetic Variation | 1 | 1989 | 1593 | 0.000 |
Why?
|